- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Concord Biotech will hold its 40th Annual General Meeting virtually to adopt the audited annual financial statements. A dividend of Rs. 10.70 per equity share for the past financial year is proposed for shareholder approval. Other key agenda items include the re-appointment of Mr. Rajiv Agarwal as a director, ratification of cost auditor remuneration at Rs. 0.037 Cr, and appointment of secretarial auditors with a fee of Rs. 0.0125 Cr. Shareholders will also vote on a special resolution to allow the company to grant loans, guarantees, or provide security up to Rs. 115 Cr to certain related entities, aimed at supporting business plans.